Mustang Bio, Inc.

MBIONASDAQUSD
0.55 USD
0.01 (1.96%)🟢LIVE (AS OF 09:34 AM EDT)
🟢Market: OPEN

MBIO is currently priced at $0.55. Technical and fundamental signals converge bearishtechnicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Aug 26, 2026.

Open?$0.56
High?$0.56
Low?$0.55
Prev. Close?$0.56
Volume?468
Avg. Volume?27.6K
VWAP?$0.55
Rel. Volume?0.02x
Bid / Ask
Bid?$0.47 × 100
Ask?$0.64 × 100
Spread?$0.17
Midpoint?$0.56
Valuation & Ratios
Market Cap?4.2M
Shares Out?6.7M
Float?6.2M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?0.56
EPS?-$0.40
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Employees
4
Market Cap
4.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2017-08-22
Address
95 SAWYER RD
WALTHAM, MA 02453
Phone: (781) 652-4500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
70
Piotroski F-Score?0/9Weak
Altman Z-Score?-35.77Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.85%Low
Short Interest?52.6K
Days to Cover?1.4
Free Float6.2M
Avg Daily Volume36.8K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.97Adequate
Cash Ratio?1.91Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.56CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
3.1CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-40.2%WEAK
ROA?
S&P
3
-19.4%WEAK
Cash Flow & Enterprise
FCF?$-4511000
Enterprise Value?$-10906597
Fundamentals ratios updated end of day